These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 34756159

  • 1. Evaluation of the seroprevalence of measles, rubella, mumps, and varicella and the requirement for additional vaccination based on the JSIPC guidelines among emergency medical technicians at eight fire stations in Narita, Japan: a project review.
    Hase R, Niiyama Y, Mito H.
    Hum Vaccin Immunother; 2022 Dec 31; 18(1):1989922. PubMed ID: 34756159
    [Abstract] [Full Text] [Related]

  • 2. Prevaccination antibody screening and immunization program for healthcare personnel against measles, mumps, rubella, and varicella in a Japanese tertiary care hospital.
    Kanamori H, Tokuda K, Ikeda S, Endo S, Ishizawa C, Hirai Y, Takahashi M, Aoyagi T, Hatta M, Gu Y, Yano H, Weber DJ, Kaku M.
    Tohoku J Exp Med; 2014 Oct 31; 234(2):111-6. PubMed ID: 25224029
    [Abstract] [Full Text] [Related]

  • 3. Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.
    Ödemiş Í, Köse Ş, Akbulut Í, Albayrak H.
    Rev Esp Quimioter; 2019 Dec 31; 32(6):525-531. PubMed ID: 31642641
    [Abstract] [Full Text] [Related]

  • 4. Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan.
    Asari S, Deguchi M, Tahara K, Taniike M, Toyokawa M, Nishi I, Watanabe M, Iwatani Y, Makimoto K.
    Am J Infect Control; 2003 May 31; 31(3):157-62. PubMed ID: 12734521
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High seroprevalence of varicella, measles, mumps, rubella and pertussis antibodies in first-grade medical students.
    Socan M, Berginc N.
    Wien Klin Wochenschr; 2008 May 31; 120(13-14):422-6. PubMed ID: 18726668
    [Abstract] [Full Text] [Related]

  • 10. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?
    Celikbas A, Ergonul O, Aksaray S, Tuygun N, Esener H, Tanir G, Eren S, Baykam N, Guvener E, Dokuzoguz B.
    Am J Infect Control; 2006 Nov 31; 34(9):583-7. PubMed ID: 17097453
    [Abstract] [Full Text] [Related]

  • 11. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M, Broder KR, Temte JL, Snider DE, Seward JF, Centers for Disease Control and Prevention (CDC).
    MMWR Recomm Rep; 2010 May 07; 59(RR-3):1-12. PubMed ID: 20448530
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Measles, mumps, rubella and varicella antibodies among international and domestic university students.
    Dyda A, Broome A, Rawlinson W, Mahimbo A, Saha A, Kefalas B, Seale H, Macintyre CR, Zwar N, Gidding HF, Heywood AE.
    J Travel Med; 2024 Jan 28; 31(1):. PubMed ID: 38195239
    [Abstract] [Full Text] [Related]

  • 15. Measles, Mumps, Rubella, and Varicella Zoster Virus Serology and Infections in Solid Organ Transplant Recipients During the First Year Posttransplantation.
    Rezahosseini O, Sørensen SS, Perch M, Ekenberg C, Møller DL, Knudsen AD, Kirkby N, Lundgren J, Lodding IP, Wareham NE, Gustafsson F, Rasmussen A, Nielsen SD.
    Clin Infect Dis; 2021 Dec 06; 73(11):e3733-e3739. PubMed ID: 32564061
    [Abstract] [Full Text] [Related]

  • 16. Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save?
    Alp E, Cevahir F, Gökahmetoglu S, Demiraslan H, Doganay M.
    J Infect Public Health; 2012 Apr 06; 5(2):127-32. PubMed ID: 22541258
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of vaccine program on IgG antibody titers for measles, rubella, varicella, and mumps in young adults in Japan: Survey between 2018 and 2021.
    Miyazaki H, Yamanaka G, Furukawa K, Ichiki M.
    J Infect Chemother; 2022 Oct 06; 28(10):1410-1414. PubMed ID: 35779802
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.
    Knuf M, Zepp F, Helm K, Maurer H, Prieler A, Kieninger-Baum D, Douha M, Willems P.
    Eur J Pediatr; 2012 Mar 06; 171(3):463-70. PubMed ID: 21935584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.